header biologics report 540x680@2x
NICE INSIGHT REPORT

Monoclonal Antibody & Recombinant Protein:
2023 Market Analysis, CDMO Pricing and Benchmarking

Coming June, 2023
  • 300 pages of unique biologics market intelligence
  • 2023 pricing data for benchmarking and informed decision making
  • Over 90 significant CDMO company profiles
  • Insight from one-on-ones with executives and industry leaders
  • Market trends and invaluable emerging technologies
header biologics report 540x680@2x

Key market insights for innovators, CDMOs and investors in the biologics industry

01 insights green icon 65x65

Master the Monoclonal Antibody & Recombinant Protein markets

Stay informed on the biologics market with comprehensive study on top CDMOs and insights into manufacturing trends. Benchmark your business with our in-depth pricing studies, which use years of primary data, and see where the market is trending.
02 benchmarking green icon 65x65

Unlock The Dynamic Potential of Biologics

Biologics manufacturing has its own unique considerations. Stay a step ahead with our report on disruptive technologies for R&D, production, and transportation of monoclonal antibodies and recombinant proteins.

Coming June, 2023

The biologics landscape is constantly evolving. The only place for informed insights from respected voices in biopharma is our Market Analysis.

The Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking provides

01 insights green icon 65x65
Up to date pricing information
for manufacture and production costs
02 overview green icon 65x65
Comprehensive overview
of the biologics CDMO landscape, including capabilities, proprietary technologies, and locations
03 analysis green icon 65x65
Analysis of the biologics market
with a pipeline overview spanning different scientific processes, therapeutic areas, regions and scales
04 market growth green icon 65x65
Market growth projections
for the biologics market, with segments including biosimilars, antibody, protein and vaccines
05 external factors green icon 65x65
In-depth scientific knowledge
with input from PhDs and SMEs across the industry
06 gears icon 65x65
Emerging technology
for manufacturing and supply chain management of biologics

Over 1300 hours of data collection and analysis
including interviews with CDMO owners, PhDs and customers

Table of Contents

biologics report form
Coming June, 2023
Request your copy of the Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking

biologics report form